Literature DB >> 8377997

Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: report of a case.

L R Hajjar1, W Kim, G H Nolan, S Turner, U R Raju.   

Abstract

BACKGROUND: Tamoxifen has been used in the adjuvant treatment of breast cancer because of its antiestrogenic effects. However, recent reports have shown it to have estrogenic effects as well. The purpose of this report is to describe a potential association between tamoxifen therapy and endometriosis. CASE: A 50-year-old postmenopausal woman who had received 2 years of adjuvant tamoxifen therapy for breast carcinoma developed extensive tumor-like endometriosis necessitating extensive pelvic and intestinal surgery.
CONCLUSION: This case report highlights the need for obstetricians and gynecologists to be familiar with the actions of tamoxifen and its potential complications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377997

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Gynaecological effects of tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

2.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

3.  Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user.

Authors:  William T Jaegle; Jason C Barnett; Bridget R Stralka; Nicole P Chappell
Journal:  Gynecol Oncol Rep       Date:  2017-10-31

4.  Bilateral ovarian endometriomas after laparoscopic hysterectomy following adjuvant tamoxifen therapy for breast cancer: A case report.

Authors:  Satoshi Nishiyama; Sotaro Hayashi; Naoki Abe; Sachino Kira; Miho Oda; Lifa Lee; Yoko To; Maki Goto; Hiroshi Tsujioka
Journal:  Case Rep Womens Health       Date:  2022-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.